Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019.
Gottlieb SL, Ndowa F, Hook EW 3rd, Deal C, Bachmann L, Abu-Raddad L, Chen XS, Jerse A, Low N, MacLennan CA, Petousis-Harris H, Seib KL, Unemo M, Vincent L, Giersing BK; Gonococcal Vaccine PPC Expert Advisory Group.
Gottlieb SL, et al. Among authors: low n.
Vaccine. 2020 Jun 9;38(28):4362-4373. doi: 10.1016/j.vaccine.2020.02.073. Epub 2020 Apr 28.
Vaccine. 2020.
PMID: 32359875
Free PMC article.
Evidence suggests serogroup B Neisseria meningitidis vaccines might provide some cross-protection against N. gonorrhoeae, and new gonococcal vaccine candidates based on several approaches are currently in preclinical development. ...Participants emphasized the need for vac …
Evidence suggests serogroup B Neisseria meningitidis vaccines might provide some cross-protection against N. gonorrhoeae, and new gon …